BONE MARROW CRYOPRESERVATION WITH ANTIFREEZE PEPTIDES

Award Information
Agency:
Department of Health and Human Services
Amount:
$49,285.00
Program:
SBIR
Contract:
N/A
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
1991
Phase:
Phase I
Agency Tracking Number:
16393
Solicitation Topic Code:
N/A
Small Business Information
Cryolife, Inc
2211 New Market Parkway, Suite, 14, Marietta, GA, 30067
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 Brockbank, Kelvin G
 Principal Investigator
 (404) 952-1660
Business Contact
 1 R43 CA53956-01
Phone: () -
Research Institution
N/A
Abstract
THIS STUDY FOCUSES ON THE USE OF ANTIFREEZE PEPTIDES IN THE DEVELOPMENT OF AN IMPROVED METHOD FOR CRYOPRESERVATION OF BONE MARROW PROGENITOR CELLS. RECOMBINANT ANTIFREEZE PEPTIDES HAVE BEEN FOUND TO INHIBIT MIGRATORY RECRYSTALIZATION DURING THAWING OF ERYTHROCYTES AND TO PERMIT REDUCTION IN DIMETHYLSULFOXIDE CONCENTRATIONS IN CRYOPRESERVATION OF THE LEUKEMIC CELL LINE KG-LA. THE OBJECTIVE OF THIS PROJECT IS TO COMBINE THE ABOVE OBSERVATIONS IN THE DESIGN OF A NOVEL BONE MARROW CRYOPRESERVATION PROCEDURE. COMBINATION OF ANTIFREEZE PEPTIDES WITH LOW LEVELS OF PENETRATING AND NON-PENETRATING CRYOPROTECTANTS SHOULD REMOVE THE PROBLEMS ENCOUNTERED, DUE TO HEMOLYSIS AND CELL CLUMPING, WITH CLASSICAL BONE MARROW CRYOPRESERVATION. SUCCESS IN THIS PROJECT MAY RESULT IN REMOVAL OF CELL PROCESSING STEPS BEFORE AND AFTER CRYOPRESERVATION; ULTIMATELY RESULTING IN REDUCED COSTS, AND REDUCED STEM CELL LOSSES DUE TO THE CYTOTOXICITY, WHICH IS ASSOCIATED WITH BONE MARROW PROCESSING, PRESERVATION, AND THAWING. THIS STUDY WILL BE PERFORMED AT THE CRYOLIFE RESEARCH AND DEVELOPMENT LABORATORIES USING RABBIT BONE MARROW.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government